ARCELLX, INC ACLX IPO will take place February, 04 on the NASDAQ exchange under the ticker ACLX.
The company is offering shares at an expected price between $15.00 and $17.00 per share with an insider lock-up period of 180 days ending on August 03, 2022.
See also: Benzinga IPO Calendar
About ARCELLX, INC
ARCELLX, INC is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
